Colleen Owens

The findings demonstrated that female gender, older age, and Caucasian race were the most likely predictors of opioid use in patients with JFMS.

Patients with rheumatoid arthritis (RA) who took biologics or triple therapy had a longer fail time than patients who took methotrexate oral monotherapy, suggesting that these treatments may be a good follow-up to failed first-line methotrexate treatment.

Major adverse cardiovascular event rates for baricitinib stabilize over time.

Methotrexate discontinuation was not observed to impact rheumatoid arthritis treatment with tocilizumab, according to an abstract presented at the 2017 American College of Rheumatology Annual Meeting.

Some patients with rheumatoid arthritis require a refined treat-to-target plan.

Low incidence of 14-3-3η in patients with long-term RA, chronic HCV with arthralgias.

Treatment for psoriatic arthritis may impact symptoms and patient-reported outcomes.

Flares and immune-related adverse events are common among patients with rheumatologic diseases but can often be successfully managed.

Study finds improved mental health resources and non-pharmacologic treatment options may be effective in reducing reduce opioid exposure among children with juvenile fibromyalgia syndrome.

Patients with active psoriatic arthritis experience significant work instability based on disease activity.

Patients with rheumatoid arthritis who switched to biologics or triple therapy had a longer time to treatment failure versus augmented oral methotrexate.

Several modalities found to be effective in the triage of psoriasis patients with musculoskeletal symptoms, according to a study presented at the 2017 American College of Rheumatology meeting.

One update reflects the committee’s recommendation of a third dose of mumps-containing vaccine in mumps outbreak settings, as determined by public health authorities.

The current influenza season is getting off to a typically slow start.

The panel agreed that Shingrix has some superior outcome data; however, some members said it was too early to make the preferential recommendation.